Cause of high variability in drug dissolution testing and its impact on setting tolerances
Authors:
- Saeed A QureshiSQSaeed A Qureshi
- Javad ShabnamJSJavad Shabnam
- 1 January 2001
- journal article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 12 (3) , 271-276
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Typical variability in drug dissolution testing: study with USP and FDA calibrator tablets and a marketed drug (glibenclamide) productEuropean Journal of Pharmaceutical Sciences, 1998
- Assessment of Pharmaceutical Quality of Furosemide Tablets from Multinational MarketsDrug Development and Industrial Pharmacy, 1998
- Improved Hydrodynamics for USP Apparatus 2Dissolution Technologies, 1996
- Industry Perspective on Dissolution Apparatus CalibrationDissolution Technologies, 1995
- A Critical Assessment of the Usp Dissolution Apparatus Suitability Test CriteriaDrug Development and Industrial Pharmacy, 1995
- Evaluation of the Performance of Prednisone and Salicylic Acid Usp Dissolution CalibratorsDrug Development and Industrial Pharmacy, 1995
- Pharmaceutical Quality of Glibenclamide Products A Multinational Postmarket Comparative StudyDrug Development and Industrial Pharmacy, 1993
- Systematic Error Associated with Apparatus 2 of the USP Dissolution Test V: Interaction of Two Tableted Prednisone Formulations with Glass and Plastic VesselsJournal of Pharmaceutical Sciences, 1984
- Systematic Error Associated with Apparatus 2 of the USP Dissolution Test IV: Effect of Air Dissolved in the Dissolution MediumJournal of Pharmaceutical Sciences, 1983
- Systematic Error Associated with Apparatus 2 of the USP Dissolution Test II: Effects of Deviations in Vessel Curvature from That of a SphereJournal of Pharmaceutical Sciences, 1982